Aspiriant LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Sell |
4,886
-373
| -7% | -$25.7K | 0.01% | 236 |
|
|
2025
Q1 | $365K | Buy |
5,259
+34
| +0.7% | +$2.36K | 0.01% | 219 |
|
|
2024
Q4 | $449K | Sell |
5,225
-157
| -3% | -$13.5K | 0.02% | 196 |
|
|
2024
Q3 | $641K | Sell |
5,382
-613
| -10% | -$73K | 0.02% | 174 |
|
|
2024
Q2 | $856K | Buy |
5,995
+1,189
| +25% | +$170K | 0.03% | 151 |
|
|
2024
Q1 | $617K | Sell |
4,806
-384
| -7% | -$49.3K | 0.03% | 174 |
|
|
2023
Q4 | $537K | Sell |
5,190
-34
| -0.7% | -$3.52K | 0.02% | 184 |
|
|
2023
Q3 | $475K | Hold |
5,224
| – | – | 0.02% | 184 |
|
|
2023
Q2 | $423K | Hold |
5,224
| – | – | 0.02% | 191 |
|
|
2023
Q1 | $416K | Buy |
5,224
+2,200
| +73% | +$175K | 0.02% | 193 |
|
|
2022
Q4 | $205K | Buy |
+3,024
| New | +$205K | 0.01% | 261 |
|
|
2017
Q2 | – | Sell |
-16,290
| Closed | -$280K | – | 223 |
|
|
2017
Q1 | $280K | Buy |
+16,290
| New | +$280K | 0.02% | 176 |
|